Vitality Biopharma competitorsClear all

Vitality Biopharma's top competitors include Futura Medical, Adamas Pharmaceuticals, Generex Biotechnology and Opiant Pharmaceuticals.
Vitality Biopharma
Vitality Biopharma
Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.
Futura Medical
Futura Medical
Futura's innovation strategy applies advanced science to develop products with compelling commercial potential.
Adamas Pharmaceuticals
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Generex Biotechnology
Generex Biotechnology
Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
Founding Date
Founding Date
2012
Founding Date
1997
Founding Date
2002
Founding Date
N/A
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Los Angeles, US HQ
Locations
Guildford, GB HQ
Locations
Emeryville, US HQ
Locations
Burlington, CA HQ
Miramar, US
Locations
Santa Monica, US HQ
London, GB
Santa Monica, US
Employees
Employees
814% increase
Employees
13
Employees
1361% increase
Employees
9200% increase
Employees
2131% increase
Valuation ($)
Valuation ($)
4.6 m
Valuation ($)
50.4 m
Valuation ($)
134.6 m
Valuation ($)
46.2 m
Valuation ($)
39.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
62
Twitter followers
N/A
Twitter followers
766
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
232134
Alexa Website Rank
193950
Alexa Website Rank
150475
Alexa Website Rank
358312
Alexa Website Rank
331763
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$54.6m (FY, 2019)
Revenue (est.)
$6.2m (FY, 2019)
Revenue (est.)
$40.5m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.5m (FY, 2019)
Cost of goods
$4.1m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$52.2m (FY, 2019)
Gross profit
$2.1m (FY, 2019)
Gross profit
$40.5m (FY, 2019)
Net income
Net income
($4.4m) (FY, 2020)
Net income
(£5.9m) (FY, 2018)
Net income
($105.2m) (FY, 2019)
Net income
($11m) (FY, 2019)
Net income
$11.6m (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 18.2m
Total funding raised
$ 82m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Futura Medical
HQ
Guildford, GB
Employees
13

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
136↑ 1% increase

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company
Generex Biotechnology
HQ
Burlington, CA
Employees
9

Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.

View company
Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
21↑ 31% increase

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company